Posizioni attive di Elisa Kieback
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
T-Knife GmbH
 T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Fondatore | 01/01/2018 | - |
| Direttore Tecnico/Scientifico/R&S | 19/01/2021 | - | |
| Amministratore Delegato | 01/01/2018 | 19/01/2021 |
Storia della carriera di Elisa Kieback
Statistiche
Distribuzione geografica
| Germania | 2 |
Posizioni
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
T-Knife GmbH
T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Health Technology |
- Borsa valori
- Insiders
- Elisa Kieback
- Esperienza
